Diphtheria-Tetanus-Pertussis Vaccine
"Diphtheria-Tetanus-Pertussis Vaccine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A vaccine consisting of DIPHTHERIA TOXOID; TETANUS TOXOID; and whole-cell PERTUSSIS VACCINE. The vaccine protects against diphtheria, tetanus, and whooping cough.
Descriptor ID |
D015721
|
MeSH Number(s) |
D20.215.894.135.535.300 D20.215.894.691.263.300 D20.215.894.691.824.300 D20.215.894.815.300
|
Concept/Terms |
Diphtheria-Tetanus-Pertussis Vaccine- Diphtheria-Tetanus-Pertussis Vaccine
- Diphtheria Tetanus Pertussis Vaccine
- Vaccine, Diphtheria-Tetanus-Pertussis
- DTwP Vaccine
- Vaccine, DTwP
- DPT Vaccine
- Vaccine, DPT
- DTP Vaccine
- Vaccine, DTP
- Di-Te-Per Vaccine
- Di Te Per Vaccine
- Vaccine, Di-Te-Per
- Diphtheria-Pertussis-Tetanus Vaccine
- Diphtheria Pertussis Tetanus Vaccine
- Vaccine, Diphtheria-Pertussis-Tetanus
|
Below are MeSH descriptors whose meaning is more general than "Diphtheria-Tetanus-Pertussis Vaccine".
Below are MeSH descriptors whose meaning is more specific than "Diphtheria-Tetanus-Pertussis Vaccine".
This graph shows the total number of publications written about "Diphtheria-Tetanus-Pertussis Vaccine" by people in this website by year, and whether "Diphtheria-Tetanus-Pertussis Vaccine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 1 | 0 | 1 |
2009 | 1 | 0 | 1 |
2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Diphtheria-Tetanus-Pertussis Vaccine" by people in Profiles.
-
Nachtigall I, Bonsignore M, Hohenstein S, Bollmann A, G?nther R, Kodde C, Englisch M, Ahmad-Nejad P, Schr?der A, Glenz C, Kuhlen R, Th?rmann P, Meier-Hellmann A. Effect of gender, age and vaccine on reactogenicity and incapacity to work after COVID-19 vaccination: a survey among health care workers. BMC Infect Dis. 2022 Mar 26; 22(1):291.
-
Brodzik R, Spitsin S, Pogrebnyak N, Bandurska K, Portocarrero C, Andryszak K, Koprowski H, Golovkin M. Generation of plant-derived recombinant DTP subunit vaccine. Vaccine. 2009 Jun 08; 27(28):3730-4.
-
Bernstein HH, Rothstein EP, Pichichero ME, Green JL, Reisinger KS, Blatter MM, Halpern J, Arbeter AM, Bernstein DI, Smith V, et al. Reactogenicity and immunogenicity of a three-component acellular pertussis vaccine administered as the primary series to 2, 4 and 6 month old infants in the United States. Vaccine. 1995 Dec; 13(17):1631-5.
-
Bernstein HH, Rothstein EP, Reisinger KS, Blatter MM, Arbeter AM, Fontana ME, Jacobs JM, Long SS, Rathfon H, Crayne O, et al. Comparison of a three-component acellular pertussis vaccine with a whole-cell pertussis vaccine in 15- through 20-month-old infants. Pediatrics. 1994 Apr; 93(4):656-9.